carrot carrot carrot Change Centers x cognizanti collaborators create-folder Data Science Decisive Infrastructure download download edit Email exit Facebook files folders future-of-work global sourcing industry info infographic linkedin location Mass Empowerment Mobile First our-latest-thinking pdf question-mark icon_rss save-article search-article search-folders settings icon_share smart-search Smart Sourcing icon_star Twitter Value Webs Virtual Capital workplace Artboard 1

Please visit the COVID-19 response page for resources and advice on managing through the crisis today and beyond.


Cognizant® Shared Investigator Platform

Cognizant® Shared Investigator Platform

Streamline clinical trials with a site-first approach

With a site-first approach, SIP provides a single platform where investigators and sponsors can collaborate, share documents and harmonize workflows to streamline clinical trials.


A new way forward

In light of the pandemic and technology breakthroughs such as AI and remote collaboration, life sciences organizations around the world are reconsidering how they conduct clinical trials.
Cognizant’s Shared Investigator Platform supports a new approach for streamlining clinical trials. As the industry’s first open, SaaS-based clinical ecosystem, Cognizant SIP connects sponsors, sites and technology providers working at home or other locations. It does so all from one place, with one sign-in.
Many leading life sciences companies have joined SIP, committing to a shared vision of common workflows, training and documents. Sponsors and sites report improved efficiencies and quicker study start-ups. The result? Faster time to market for new therapies—and more time helping patients.
Learn more about our Life Sciences solutions for your business.

Recently published insights

Today's new normal
Today's new normal

Cognizant SIP for COVID-19

Agile drug development
Agile drug development:

The new urgency required


Related thinking

Reinventing clinical trials for a stay-at-home world

As current social distancing guidelines prevent most face-to-face clinical trials, now’s the time to move to decentralized clinical trials.

Accelerating clinical trials: The new and future normal

Keeping clinical trials operating efficiently during the COVID-19 pandemic is forcing the life sciences industry to adopt new working practices.



Larissa Comis

Product Lead, Shared Investigator Platform

Om Prakash

AVP Life Sciences, Head of Shared Investigator Platform

Lestter Cruz Serrano

Medical Affairs Advisor, Shared Investigator Platform

Take the first step

Serving customers by looking forward as well as back is a big promise, but the power of today’s new digital capabilities is vast and growing. Let’s talk about how digital can work for your business.

Please Enter Valid First Name
Please Enter a Valid Email Address
Please Enter Valid Company Name
Please Enter Valid Contact Number
Please Input the Region
Please Input the Inquiry Type
Please Input the SubInquiry Type
Please Enter A Message

Thank you for your interest in Cognizant.

We’ll be in touch soon.